fluzoparil

DRUG2 trials

Sponsors

Shandong Cancer Hospital and Institute, Liu Zhenhua

Conditions

Extensive Stage Small Cell Lung CancerGlioblastoma

Phase 2

A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

Shandong Cancer Hospital and InstituteGlioblastoma

Start: 2020-09-30End: 2022-08-31Target: 50Updated: 2020-09-17

Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer

Liu ZhenhuaExtensive Stage Small Cell Lung Cancer

Start: 2021-06-30End: 2023-06-30Target: 50Updated: 2021-06-21

Related Papers

Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study)

BMC Cancer2023-08-148 citations